Download 'STETHO' App
Hindustan Wellness·" to view your digitized report
lncun·� 1 · llul1h M11nn�trntn1 Cornpnn� (Turn overleaf to know more) ,;. ti
Sample: Collected °'1:
Mr. C K Anand Prakash 25 Mar 2021 2:15PM
Nasal & throat Swab
Patient ID: 2101151112 Recieved On:
Age: 26 Y Gender: malt 26 Mar 2021 2:00PM
ReferDoetor : self Rcponedon:
SR FI D: 0606200626614 26 M.>r 2021 2:00PM
Investigation Observed Value Unit Blologlcal Ref.Interval
t!'!OLECULAR BIOLOGY
SARS COV -2 REAL TIME PCR
SARS-CoV-2 (COVID-19)
NEGATIVE Aease refer the table below
RT.PCR
Oinical Significance:
-ult A!marks
RlsMM! R,I<\ $Mdlclo SA,RS,Q:lv-2 Cle<ected .
NlCECM! R,l<I specflclo SA.RS-0:lv-2 r-ordl!CElCled.
h:orcl.lsive �""""'klstqi on lresh sanpe IS rOCOITTTll!\'.le
ICMR Co.kl• 19 lab f\>glstratlon number Is Hl'IB'l.Gt
Tut cooducted on lmal & Throat $Nab Sanpk,1'.
Lowor rvsp;ratory tract •amploo like Spul\Jm, IW., Er asp;rato oro appropri,to •amplu 05pocioflyin 50VorO and progroniw lung diooa5o.
l<indlyconsult ra'11rrlng Physician/ .Aulhonmd hospru,ls for -oprillto follow up.
Covld-19Toslconduaed as per kits apprOYGd byICMR/C6M)/IJSFDI.
Umltallons:
1. Nl;tgativo re1utt5 do not preclude COIID-19 and 1hould not be usod as the sokt basis for J)aio!W managemont decisions. NDga:Mt rnub must bo combined with
dlnlcal observations, padent history, and op;domlologtcal lnfarmllllon.
2. Prosenco of Inhibitors, mutallons or lnsufflcloot FN\ Spadllc lo SARS-CoV-2 ca, lnffuonoa Iha test rasuft. l<indlyettrelate tho rosuts wMh dlnlcal findings.
l Pooltlve results but do not rue out bactarlal lnfedlon or co-lnlectlon wtth other vlnloes.
'4. q,tlmum spodman typos ond tilling ror pc,ok vlrnl fowls during lnloctlons coosod by2019-nCoV h:MI not boon dotormlnod. Colloctlon of multfplo spodmons (typos
ond time p04nt1) h'orn the..,., patient mll'f be nooasssyto dotoct tho vln11.
5. K the virus muta•s In the rRT-l'Oltargel roglon, 201!HiCoV may not be detected or maybe detectod less p,adictably. Inhibitors or olher typos d lnterfon,nce may
prOdleo a false negative result.
6. The porform111co d this test hos not been established for moritonng lrealment ol 2019-nCoV lnft>dlon.
Comments: SARS-CoV-2, formerly known as 2019-<,CoV, Is tho cau•atlw agent of the a,rona,,iruo dlseilSO 2019 (COJll).19� Main symptoms ol tha disease Include fewr,
cough Md shortness of breath. The vtrus Is sp-ead t.Aa pen5-on---to--person contact through respiratorydroplets producad whon a person coughs or snH?es. The SAR>
CoV-2 FN\ is gonorollydoloctalllo In naoopha-yngoal/orq:,ha'}'ngeal swabs during tho acute phoso ol inlodion. PIJ6ijr,,o results are ;.-1w of actlw inlodion. !\>of
Time PCRassaytargets spodlic genes and can be used for dillgnosls of SARSCoV-2 virus Infection which amtrib<-Ces to severe upper resp;ratorydlstreu,
compllcallons
R,fnronces:
1. Loborlltorytestlng for cxwONIYlrus dlseao• 2019 (COll[).19) In suspoctod human casas. Interim guldanoa. World 11talth 0'ganlzatlon.
2. Dwe et al• ..ICM. 2011
l Ill Eilgl. J. Med. 2020, 382. 92!Hl36
End Of The Repor1--·---·
CXHJTlCNS CF LAIICRATCRV11:ST11'3& REPCRTlNG
1. I is presured 11-.it thetesl sarrj:lebelc:rgs lolt'e p,tiert- crid<'1li"oedil lt"e test ra:iuslion fOOT 4. The resulsd a labcraay tcstared,pe,mt on lhoq.aiy or thasanpe as well
2. Hn,Lsm Wllress oortrrm m al l8ilS hale beU1 porfarred a assayed wilh ng,ost <JJafity as lhoassay loch'dogy.
5. -d<tlys COi.ld be becaJSed ll"<Xll"tr0ledci'cU'l"S""""6. e.g. assay ru,
-• cfrlcel s,i.ay & ledncal lrwgrty. raue.
l A rec,.esled leSl lli\11 nd be porfcrmld �: 6. l.alora01Y "'81As sh:Jud be c:metaedwih cillC81 riomum lo_,,.,,. Final
a. �nm roc,;,,ed is insllflCierl a �lam spocirran qllllyIs ursafsfactcry
b.h:aract spocm,n type <11gosis.
c. �I fer 186llrg Is wil-.tawnby lt'e ad!)'i-g doc:la a jXfler'I d Thlre ll ad� between 7. Testn,sutsa-erdv,ldlaMlda:iogalp.rpcse&. B.hcased q.,msc,
�testresw p1eesecar1e1..-,.,ca,,($1C831073J83�
lte -on Ille sparm<Xlliaiv aid tre rme on lte &€t51 roq..isfun ronn
�
OR. MEENAKSHI Dr.KRISHNA KANT TANEJA Or.Pankaj Sharma
(Authorized Signatory) Chief of Lab-Mol Bio. (Authorized Signatory)
(Authorized Signatory)
Hindustan Wellness Pvt Ltd.• Building No. I 07, Sector - 44, Gurgaon - 122003
Take a Virtual Tour of Our World Class NABL Accredited Lab on www.hlndustanwellness.com
Tel: 9810-9810-73 / 83 I cus1omer.servicc@hindustanwellness.com
